MARKET

BIOC

BIOC

Biocept Inc
NASDAQ
1.350
-0.030
-2.17%
After Hours: 1.390 +0.04 +2.96% 19:41 09/28 EDT
OPEN
1.370
PREV CLOSE
1.380
HIGH
1.400
LOW
1.350
VOLUME
64.86K
TURNOVER
0
52 WEEK HIGH
29.10
52 WEEK LOW
0.8000
MARKET CAP
3.55M
P/E (TTM)
-0.0403
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at BIOC last week (0918-0922)?
Weekly Report · 4d ago
Maxim Group Remains a Hold on Biocept (BIOC)
TipRanks · 09/22 15:46
Enrollment Completed In The Feasibility Phase Of The FORESEE Clinical Trial With Biocept's CNSide Assay To Evaluate Patients With Leptomeningeal Metastases
Benzinga · 09/21 12:21
Weekly Report: what happened at BIOC last week (0911-0915)?
Weekly Report · 09/18 12:17
BIOC, SLE and PCT among pre-market losers
Seeking Alpha · 09/14 12:35
GRAB, BIOC and PSTV among pre-market losers
Seeking Alpha · 09/13 12:18
Weekly Report: what happened at BIOC last week (0904-0908)?
Weekly Report · 09/11 12:15
Crude Oil Moves Higher; Kroger Earnings Beat Estimates
Benzinga · 09/08 18:57
More
About BIOC
Biocept, Inc. is a molecular oncology diagnostics company. The Company focuses on developing and commercializing clinical diagnostic laboratory assays designed to identify rare tumor cells and cell-free tumor deoxyribonucleic acid (DNA) from blood and cerebrospinal fluid (CSF). Its product is branded and trademarked under the name CNSide. CNSide encompasses a suite of cellular and molecular technologies intended to aid medical professionals in CSF analysis and central nervous system (CNS) disease management in patients with solid tumors. It offers and conducts its commercialized diagnostic assays, which include cell capture and enumeration, immunocytochemistry, fluorescent in situ hybridization (FISH), and next generation sequencing (NGS). It has commercialized its CNSide assays for detecting and characterizing many different carcinomas and melanoma. These assays utilize its dual cellular and ctDNA technology platforms and provide biomarker analysis from a patient’s CSF sample.

Webull offers kinds of Biocept Inc stock information, including NASDAQ:BIOC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BIOC stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BIOC stock methods without spending real money on the virtual paper trading platform.